{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T19:43:03Z","timestamp":1788982983937,"version":"build-2803163510"},"reference-count":143,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005156","name":"Alexander von Humboldt-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023561","name":"Ministerio de Universidades","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023561","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.bioorg.2025.109057","type":"journal-article","created":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T22:10:16Z","timestamp":1759702216000},"page":"109057","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Innovative design and synthesis of dual-acting hCA IX\/CDK-2 inhibitors through hetero ring fused pyrimidine utilization for cutting-edge anticancer therapy: Zein nanoparticles for in vivo lung cancer treatment"],"prefix":"10.1016","volume":"166","author":[{"given":"Heba M.","family":"Abosalim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek F.","family":"El-Moselhy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabaweya","family":"Sharafeldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Giovannuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paloma","family":"Begines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed S.","family":"Nafie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherif Ashraf","family":"Fahmy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed K.","family":"Diab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asaad","family":"Babker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mervat H.","family":"El-Hamamsy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haytham O.","family":"Tawfik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.109057_bb0005","series-title":"Global cancer burden growing, amidst mounting need for services, in","author":"WHO","year":"2024"},{"key":"10.1016\/j.bioorg.2025.109057_bb0010","series-title":"Understanding End-of-Life Care: Psychological Approaches to Cancer Care","author":"Vaiphei","year":"2025"},{"key":"10.1016\/j.bioorg.2025.109057_bb0015","doi-asserted-by":"crossref","first-page":"8362","DOI":"10.7150\/thno.39816","article-title":"Strategy to enhance lung cancer treatment by five essential elements: inhalation delivery, nanotechnology, tumor-receptor targeting, chemo-and gene therapy","volume":"9","author":"Garbuzenko","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.bioorg.2025.109057_bb0020","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202100078","article-title":"Nanotechnology: breaking the current treatment limits of lung cancer","volume":"10","author":"Li","year":"2021","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.bioorg.2025.109057_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2019.107438","article-title":"Drug resistance to targeted therapeutic strategies in non-small cell lung cancer","volume":"206","author":"Liu","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bioorg.2025.109057_bb0030","doi-asserted-by":"crossref","first-page":"9663","DOI":"10.1007\/s11033-023-08809-3","article-title":"Cancer treatment therapies: traditional to modern approaches to combat cancers","volume":"50","author":"Kaur","year":"2023","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.bioorg.2025.109057_bb0035","doi-asserted-by":"crossref","first-page":"226","DOI":"10.2174\/0122103031304556240430161553","article-title":"From conventional to cutting-edge: a comprehensive review on drug delivery systems","volume":"14","author":"Vikal","year":"2024","journal-title":"Drug Deliv. Lett."},{"key":"10.1016\/j.bioorg.2025.109057_bb0040","article-title":"Nanotechnology based drug delivery system: current strategies and emerging therapeutic potential for medical science","volume":"63","author":"Sahu","year":"2021","journal-title":"J. Drug Del. Sci. Technol."},{"key":"10.1016\/j.bioorg.2025.109057_bb0045","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12645-023-00199-2","article-title":"Non-small cell lung cancer targeted nanoparticles with reduced side effects fabricated by flash nanoprecipitation","volume":"14","author":"Wang","year":"2023","journal-title":"Cancer Nanotechnol."},{"key":"10.1016\/j.bioorg.2025.109057_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2023.113419","article-title":"Nano delivery system for paclitaxel: recent advances in cancer theranostics","volume":"228","author":"Ying","year":"2023","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.bioorg.2025.109057_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2025.130166","article-title":"Development of 9H-purine scaffold as novel CDK2 inhibitors: design, synthesis, and biological evaluation","volume":"122","author":"Zhang","year":"2025","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.109057_bb0060","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-0044-1789577","article-title":"Recent development of CDK2 inhibitors as anticancer drugs: An update (2015\u20132023)","volume":"6","author":"Jin","year":"2024","journal-title":"Pharmaceutical Fronts"},{"key":"10.1016\/j.bioorg.2025.109057_bb0065","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1158\/0008-5472.CAN-14-1494","article-title":"Dmitrovsky, CDK2 inhibition causes anaphase catastrophe in lung cancer through the centrosomal protein CP110","volume":"vol. 75","author":"Hu","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2025.109057_bb0070","first-page":"109","article-title":"Targeting the cyclin E-Cdk-2 complex represses lung cancer growth by triggering anaphase catastrophe, clinical cancer research\u202f: an official journal of the American association for","volume":"16","author":"Galimberti","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2025.109057_bb0075","doi-asserted-by":"crossref","first-page":"6356","DOI":"10.1021\/acs.jmedchem.1c02190","article-title":"Lessons learned from past cyclin-dependent kinase drug discovery efforts","volume":"65","author":"Xie","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109057_bb0080","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1080\/14756366.2022.2086866","article-title":"Synthesis, biological evaluation, and in silico studies of new CDK2 inhibitors based on pyrazolo[3,4-d]pyrimidine and pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold with apoptotic activity","volume":"37","author":"Mandour","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109057_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114190","article-title":"Discovery of new carbonic anhydrase IX inhibitors as anticancer agents by toning the hydrophobic and hydrophilic rims of the active site to encounter the dual-tail approach","volume":"232","author":"Tawfik","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109057_bb0090","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1021\/acs.chemrev.4c00278","article-title":"Multiple binding modes of inhibitors to human carbonic anhydrases: An update on the Design of Isoform-Specific Modulators of activity","volume":"125","author":"D\u2019Ambrosio","year":"2025","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2025.109057_bb0095","doi-asserted-by":"crossref","first-page":"7406","DOI":"10.1021\/acs.jmedchem.4c00239","article-title":"Discovery and mechanistic studies of dual-target hits for carbonic anhydrase IX and VEGFR-2 as potential agents for solid tumors: X-ray, In Vitro, In Vivo, and In Silico Investigations of Coumarin-Based Thiazoles","volume":"67","author":"Hefny","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109057_bb0100","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2147\/JEP.S265620","article-title":"Experimental carbonic anhydrase inhibitors for the treatment of hypoxic tumors","author":"Supuran","year":"2020","journal-title":"J. Exp. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.109057_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbcan.2024.189120","article-title":"Carbonic anhydrase IX: An atypical target for innovative therapies in cancer","volume":"1879","author":"Ronca","year":"2024","journal-title":"Biochimica et Biophysica Acta (BBA)-Rev. Cancer"},{"key":"10.1016\/j.bioorg.2025.109057_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105888","article-title":"Insights into the effect of elaborating coumarin-based aryl enaminones with sulfonamide or carboxylic acid functionality on carbonic anhydrase inhibitory potency and selectivity","volume":"126","author":"Ibrahim","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109057_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40675-017-0062-7","article-title":"Hypoxia-inducible factors and Cancer","volume":"3","author":"Jun","year":"2017","journal-title":"Curr. Sleep Med. Rep."},{"key":"10.1016\/j.bioorg.2025.109057_bb0120","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.drudis.2019.12.001","article-title":"Targeting CDK2 in cancer: challenges and opportunities for therapy","volume":"25","author":"Tadesse","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioorg.2025.109057_bb0125","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10555-019-09799-0","article-title":"The role of carbonic anhydrase IX in cancer development: links to hypoxia, acidosis, and beyond","volume":"38","author":"Pastorekova","year":"2019","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.bioorg.2025.109057_bb0130","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.32604\/or.2024.052130","article-title":"Hypoxia-inducible factor 1alpha and vascular endothelial growth factor in glioblastoma Multiforme: a systematic review going beyond pathologic implications","volume":"32","author":"Vageli","year":"2024","journal-title":"Oncol. Res."},{"key":"10.1016\/j.bioorg.2025.109057_bb0135","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s12032-025-02973-1","article-title":"From cell cycle control to cancer therapy: exploring the role of CDK1 and CDK2 in tumorigenesis","volume":"42","author":"Gupta","year":"2025","journal-title":"Med. Oncol."},{"key":"10.1016\/j.bioorg.2025.109057_bb0140","doi-asserted-by":"crossref","first-page":"5646","DOI":"10.1016\/j.bmcl.2013.08.019","article-title":"Effect of incorporating a thiophene tail in the scaffold of acetazolamide on the inhibition of human carbonic anhydrase isoforms I, II, IX and XII","volume":"23","author":"Biswas","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.109057_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104026","article-title":"Chawla, Thiophene-based derivatives as anticancer agents: An overview on decade\u2019s work","volume":"101","author":"Archna","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109057_bb0150","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.2174\/1385272825666210303112858","article-title":"Synthesis of heterocyclic compounds through multicomponent reactions using 6-Aminouracil as starting reagent","volume":"25","author":"Mohajer","year":"2021","journal-title":"Curr. Org. Chem."},{"key":"10.1016\/j.bioorg.2025.109057_bb0155","doi-asserted-by":"crossref","first-page":"15610","DOI":"10.1039\/C8NJ02081G","article-title":"Antibacterial activity of synthetic pyrido [2, 3-d] pyrimidines armed with nitrile groups: POM analysis and identification of pharmacophore sites of nitriles as important pro-drugs","volume":"42","author":"Dongre","year":"2018","journal-title":"New J. Chem."},{"key":"10.1016\/j.bioorg.2025.109057_bb0160","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/jlcr.3405","article-title":"Synthesis of the derivatives of 6-amino-uracil labelled with 14C","volume":"59","author":"Elbert","year":"2016","journal-title":"J. Label. Compd. Radiopharm."},{"key":"10.1016\/j.bioorg.2025.109057_bb0165","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.3390\/molecules28093913","article-title":"Novel pyrimidine derivatives as antioxidant and anticancer agents: design, synthesis and molecular modeling studies","volume":"28","author":"Myriagkou","year":"2023","journal-title":"Molecules"},{"issue":"2021","key":"10.1016\/j.bioorg.2025.109057_bb0170","first-page":"329","article-title":"Aminouracil and aminothiouracil as versatile precursors for a variety of heterocyclic systems, ARKIVOC: online","author":"Diab","year":"2021","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.bioorg.2025.109057_bb0175","doi-asserted-by":"crossref","first-page":"8876","DOI":"10.1080\/07391102.2022.2138551","article-title":"Synthesis, crystallographic, DNA binding, and molecular docking\/dynamic studies of a privileged chalcone-sulfonamide hybrid scaffold as a promising anticancer agent","volume":"41","author":"Shaldam","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bioorg.2025.109057_bb0180","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1039\/C8OB00627J","article-title":"An improved synthesis of pyrido [2, 3-d] pyrimidin-4 (1H)-ones and their antimicrobial activity","volume":"16","author":"Fares","year":"2018","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bioorg.2025.109057_bb0185","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/slct.202004088","article-title":"Design, synthesis and molecular docking of chalcone derivatives as potential anticancer agents","volume":"6","author":"Abosalim","year":"2021","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bioorg.2025.109057_bb0190","doi-asserted-by":"crossref","first-page":"23437","DOI":"10.1038\/s41598-021-02792-0","article-title":"Pyrazoline derivatives as promising novel antischistosomal agents","volume":"11","author":"Morais","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2025.109057_bb0195","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.1039\/D3OB00792H","article-title":"Synthesis, reactions and application of chalcones: a systematic review","volume":"21","author":"Shalaby","year":"2023","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bioorg.2025.109057_bb0200","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2174\/1570193X17999200511010402","article-title":"Synthesis and biological evaluation of Pyrido (2, 3-d) pyrimidines","volume":"18","author":"Yousif","year":"2021","journal-title":"Mini-Rev. Org. Chem."},{"key":"10.1016\/j.bioorg.2025.109057_bb0205","doi-asserted-by":"crossref","first-page":"103846","DOI":"10.1016\/j.arabjc.2022.103846","article-title":"Novel pyridine and pyrimidine derivatives as promising anticancer agents: a review","volume":"15","author":"Albratty","year":"2022","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.bioorg.2025.109057_bb0210","doi-asserted-by":"crossref","first-page":"986","DOI":"10.3390\/molecules21080986","article-title":"Recent advances in metal-free quinoline synthesis","volume":"21","author":"Ramann","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.109057_bb0215","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1080\/14756366.2022.2062752","article-title":"Design, synthesis, and anti-cancer evaluation of new pyrido [2, 3-d] pyrimidin-4 (3H)-one derivatives as potential EGFRWT and EGFRT790M inhibitors and apoptosis inducers","volume":"37","author":"Elzahabi","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109057_bb0220","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/14756366.2017.1404593","article-title":"Symmetric molecules with 1, 4-triazole moieties as potent inhibitors of tumour-associated lactate dehydrogenase-a","volume":"33","author":"Altamimi","year":"2018","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109057_bb0225","first-page":"1","article-title":"Synthetic routes for the development of Piperazine-based Acetanilides and their medicinal importance","author":"Rafiq","year":"2023","journal-title":"Polycycl. Aromat. Compd."},{"key":"10.1016\/j.bioorg.2025.109057_bb0230","doi-asserted-by":"crossref","first-page":"103422","DOI":"10.1016\/j.bioorg.2019.103422","article-title":"Design, synthesis, molecular modeling, in vivo studies and anticancer evaluation of quinazolin-4 (3H)-one derivatives as potential VEGFR-2 inhibitors and apoptosis inducers","volume":"94","author":"Mahdy","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109057_bb0235","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1021\/acs.jmedchem.3c02279","article-title":"Discovery of novel Pyridazine-tethered sulfonamides as carbonic anhydrase II inhibitors for the Management of Glaucoma","author":"Tawfik","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109057_bb0240","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1080\/14756366.2022.2055553","article-title":"4-Anilinoquinazoline-based benzenesulfonamides as nanomolar inhibitors of carbonic anhydrase isoforms I, II, IX, and XII: design, synthesis, in-vitro, and in-silico biological studies","volume":"37","author":"Nada","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109057_bb0245","doi-asserted-by":"crossref","first-page":"106791","DOI":"10.1016\/j.bioorg.2023.106791","article-title":"New quinazoline sulfonamide derivatives as potential anticancer agents: identifying a promising hit with dual EGFR\/VEGFR-2 inhibitory and radiosensitizing activity","volume":"140","author":"Ghorab","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109057_bb0250","doi-asserted-by":"crossref","first-page":"10353","DOI":"10.1039\/D3RA00123G","article-title":"Novel asymmetrical azines appending 1, 3, 4-thiadiazole sulfonamide: synthesis, molecular structure analyses, in silico ADME, and cytotoxic effect","volume":"13","author":"Bondock","year":"2023","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2025.109057_bb0255","first-page":"1","article-title":"Docking, synthesis, and anticancer assessment of novel quinoline-amidrazone hybrids","volume":"71","author":"Abdullah","year":"2024","journal-title":"Pharmacia"},{"key":"10.1016\/j.bioorg.2025.109057_bb0260","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3998\/ark.5550190.0009.102","article-title":"Reactions of hydrazonoyl halides with heterocyclic thiones. Convenient methodology for heteroannulation, synthesis of spiroheterocycles and heterocyclic ring transformation","volume":"1","author":"Shawali","year":"2008","journal-title":"Arkivoc"},{"key":"10.1016\/j.bioorg.2025.109057_bb0265","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1002\/jhet.3901","article-title":"Efficient synthesis and in silico study of some novel pyrido [2, 3-d][1, 2, 4] triazolo [4, 3-a] pyrimidine derivatives","volume":"57","author":"Abdelrazek","year":"2020","journal-title":"J. Heterocyclic Chem."},{"key":"10.1016\/j.bioorg.2025.109057_bb0270","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ejmech.2014.06.027","article-title":"Synthesis and antitumor activity of pyrido [2, 3-d] pyrimidine and pyrido [2, 3-d][1, 2, 4] triazolo [4, 3-a] pyrimidine derivatives that induce apoptosis through G1 cell-cycle arrest","volume":"83","author":"Fares","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109057_bb0275","doi-asserted-by":"crossref","first-page":"4612","DOI":"10.1016\/j.bmc.2009.04.061","article-title":"6-Amino-2-mercapto-3H-pyrimidin-4-one derivatives as new candidates for the antagonism at the P2Y12 receptors","volume":"17","author":"Crepaldi","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109057_bb0280","doi-asserted-by":"crossref","first-page":"7666","DOI":"10.1021\/acsomega.2c07285","article-title":"Terminators or guardians? Design, synthesis, and cytotoxicity profiling of chalcone-sulfonamide hybrids","volume":"8","author":"Aboukhatwa","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioorg.2025.109057_bb0285","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1002\/1099-0690(200207)2002:14<2356::AID-EJOC2356>3.0.CO;2-S","article-title":"Synthesis of [1\u2032,2\u2032,5\u2032,2-13C4]-2\u2032-deoxy-D-adenosine by a Chemoenzymatic strategy to enable labelling of any of the 215 Carbon-13 and Nitrogen-15 Isotopomers","volume":"2002","author":"Ouwerkerk","year":"2002","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.bioorg.2025.109057_bb0290","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.molstruc.2016.05.064","article-title":"Microwave assisted regioselective synthesis and 2D-NMR studies of novel azoles and azoloazines utilizing fluorine-containing building blocks","volume":"1121","author":"Al-Bogami","year":"2016","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2025.109057_bb0295","doi-asserted-by":"crossref","first-page":"6412","DOI":"10.1016\/j.arabjc.2020.05.042","article-title":"Design, characterization and quantum chemical computations of a novel series of pyrazoles derivatives with potential anti-proinflammatory response","volume":"13","author":"Burboa-Schettino","year":"2020","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.bioorg.2025.109057_bb0300","doi-asserted-by":"crossref","first-page":"113283","DOI":"10.1016\/j.ejmech.2021.113283","article-title":"Development of novel benzofuran-based SLC-0111 analogs as selective cancer-associated carbonic anhydrase isoform IX inhibitors","volume":"216","author":"Shaldam","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109057_bb0305","doi-asserted-by":"crossref","first-page":"16756","DOI":"10.1038\/s41598-022-21024-7","article-title":"Synthesis and anticancer activity of new benzensulfonamides incorporating s-triazines as cyclic linkers for inhibition of carbonic anhydrase IX","volume":"12","author":"Zain-Alabdeen","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2025.109057_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.138148","article-title":"Novel sulfonamide-tethered Schiff bases as anti-proliferative agents with VEGFR-2 inhibitory activity: synthesis, biological assessment, and molecular dynamic simulations","volume":"1309","author":"Shaldam","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2025.109057_bb0315","doi-asserted-by":"crossref","first-page":"2300449","DOI":"10.1002\/ardp.202300449","article-title":"Identification of 3-(5-cyano-6-oxo-pyridin-2-yl)benzenesulfonamides as novel anticancer agents endowed with EGFR inhibitory activity","volume":"357","author":"Shaldam","year":"2024","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2025.109057_bb0320","article-title":"Multi-and poly-pharmacology of carbonic anhydrase inhibitors","volume":"100004","author":"Supuran","year":"2024","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bioorg.2025.109057_bb0325","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1080\/14756366.2020.1801674","article-title":"Inhibitory activity against carbonic anhydrase IX and XII as a candidate selection criterion in the development of new anticancer agents","volume":"35","author":"Krasavin","year":"2020","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109057_bb0330","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1016\/j.bmcl.2010.05.009","article-title":"Carbonic anhydrase inhibitors","volume":"20","author":"Supuran","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.109057_bb0335","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1080\/10717544.2022.2057618","article-title":"Nano-liposomal zein hydrolysate for improved apoptotic activity and therapeutic index in lung cancer treatment","volume":"29","author":"Mazloum-Ravasan","year":"2022","journal-title":"Drug Deliv."},{"key":"10.1016\/j.bioorg.2025.109057_bb0340","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.ijrobp.2021.02.055","article-title":"A multi-institutional analysis of adjuvant chemotherapy and radiation sequence in women with stage IIIC endometrial cancer","volume":"110","author":"Hathout","year":"2021","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.bioorg.2025.109057_bb0345","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3390\/pharmaceutics11110562","article-title":"Development of folate-functionalized PEGylated Zein nanoparticles for ligand-directed delivery of paclitaxel","volume":"11","author":"Soe","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioorg.2025.109057_bb0350","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.actbio.2018.12.007","article-title":"Co-delivery of cisplatin and doxorubicin by covalently conjugating with polyamidoamine dendrimer for enhanced synergistic cancer therapy","volume":"84","author":"Guo","year":"2019","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bioorg.2025.109057_bb0355","article-title":"Recent advances in brain delivery of synthetic and natural nano therapeutics: reviving hope for Alzheimer\u2019s disease patients","volume":"105047","author":"Nady","year":"2023","journal-title":"J. Drug Delivery Sci.Technol."},{"key":"10.1016\/j.bioorg.2025.109057_bb0360","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1021\/acsomega.2c06390","article-title":"Essential oils extracted from boswellia sacra oleo gum resin loaded into PLGA\u2013PCL nanoparticles: enhanced cytotoxic and apoptotic effects against breast cancer cells","volume":"8","author":"Azzazy","year":"2022","journal-title":"ACS omega"},{"key":"10.1016\/j.bioorg.2025.109057_bb0365","doi-asserted-by":"crossref","first-page":"42115","DOI":"10.1021\/acsomega.2c04525","article-title":"Thermosensitive liposomes encapsulating nedaplatin and picoplatin demonstrate enhanced cytotoxicity against breast cancer cells","volume":"7","author":"Fahmy","year":"2022","journal-title":"ACS omega"},{"key":"10.1016\/j.bioorg.2025.109057_bb0370","doi-asserted-by":"crossref","first-page":"25876","DOI":"10.1021\/acsomega.1c04297","article-title":"Stimuli-responsive amphiphilic pillar [n] arene Nanovesicles for targeted delivery of Cancer drugs","volume":"6","author":"Fahmy","year":"2021","journal-title":"ACS omega"},{"key":"10.1016\/j.bioorg.2025.109057_bb0375","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3797\/scipharm.1103-17","article-title":"Enhanced antihypertensive activity of candesartan cilexetil nanosuspension: formulation, characterization and pharmacodynamic study","volume":"79","author":"Detroja","year":"2011","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.bioorg.2025.109057_bb0380","doi-asserted-by":"crossref","first-page":"5244","DOI":"10.3390\/cancers14215244","article-title":"Molecular engines, therapeutic targets, and challenges in pediatric brain tumors: a special emphasis on hydrogen sulfide and RNA-based nano-delivery","volume":"14","author":"Fahmy","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.bioorg.2025.109057_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.143898","article-title":"Tyrosine kinase inhibitor-loaded zein nanoparticles with enhanced drug delivery and anticancer efficacy","volume":"314","author":"Jayalakshmi","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioorg.2025.109057_bb0390","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1080\/10717544.2019.1704942","article-title":"Zein nanoparticles as nontoxic delivery system for maytansine in the treatment of non-small cell lung cancer","volume":"27","author":"Yu","year":"2020","journal-title":"Drug Deliv."},{"key":"10.1016\/j.bioorg.2025.109057_bb0395","doi-asserted-by":"crossref","first-page":"944","DOI":"10.3390\/pharmaceutics17070944","article-title":"Zein-based Nanocarriers: advances in Oral drug delivery","volume":"17","author":"Liu","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioorg.2025.109057_bb0400","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1007\/s13346-022-01286-4","article-title":"Functionalized zein nanoparticles targeting neonatal fc receptor to enhance lung absorption of peptides","volume":"13","author":"Hameedat","year":"2023","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.bioorg.2025.109057_bb0405","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.999373","article-title":"Zein-based nano-delivery systems for encapsulation and protection of hydrophobic bioactives: a review","volume":"9","author":"Yan","year":"2022","journal-title":"Front. Nutr."},{"key":"10.1016\/j.bioorg.2025.109057_bb0410","first-page":"5324","article-title":"Psoralidin\u2013cucurbit [7] uril complex with improved solubility to tackle human colorectal cancer: experimental and computational study, materials","volume":"4","author":"Ponte","year":"2023","journal-title":"Advances"},{"key":"10.1016\/j.bioorg.2025.109057_bb0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpcs.2020.109749","article-title":"Chitosan coated magnetic nanoparticles as carriers of anticancer drug Telmisartan: pH-responsive controlled drug release and cytotoxicity studies","volume":"148","author":"Dhavale","year":"2021","journal-title":"J. Phys. Chem. Solids"},{"key":"10.1016\/j.bioorg.2025.109057_bb0420","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/asia.201301105","article-title":"Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release","volume":"9","author":"Hu","year":"2014","journal-title":"Chem\u2013An Asian J."},{"key":"10.1016\/j.bioorg.2025.109057_bb0425","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.3390\/pharmaceutics16101282","article-title":"Synergistic enhancement of carboplatin efficacy through pH-sensitive nanoparticles formulated using naturally derived Boswellia extract for colorectal Cancer therapy","volume":"16","author":"Fahmy","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioorg.2025.109057_bb0430","doi-asserted-by":"crossref","first-page":"10959","DOI":"10.3390\/ijms241310959","article-title":"Pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine sulfonamides as an important scaffold for anticancer drug discovery\u2014in vitro and in silico evaluation","volume":"24","author":"Kciuk","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.109057_bb0435","doi-asserted-by":"crossref","first-page":"267","DOI":"10.4062\/biomolther.2023.149","article-title":"Unlocking the therapeutic potential of BCL-2 associated protein family: exploring BCL-2 inhibitors in cancer therapy","volume":"32","author":"El Dakkak","year":"2024","journal-title":"Biomol. Ther."},{"key":"10.1016\/j.bioorg.2025.109057_bb0440","doi-asserted-by":"crossref","first-page":"15109","DOI":"10.1038\/s41598-025-96788-9","article-title":"Deciphering the effects of bixin on pulmonary alveolar adenocarcinoma migration and proliferation via targeting BAX\/BCL-2 and cyclin D1","volume":"15","author":"Varghese","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2025.109057_bb0445","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1080\/13543784.2021.2014813","article-title":"Carbonic anhydrase inhibitors: an update on experimental agents for the treatment and imaging of hypoxic tumors","volume":"30","author":"Supuran","year":"2021","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.bioorg.2025.109057_bb0450","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1080\/13543776.2023.2245971","article-title":"Targeting carbonic anhydrases for the management of hypoxic metastatic tumors","volume":"33","author":"Supuran","year":"2023","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bioorg.2025.109057_bb0455","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1021\/acsbiomaterials.3c01540","article-title":"Revolutionizing cancer treatment: the promising horizon of Zein nanosystems","volume":"10","author":"Preetam","year":"2024","journal-title":"ACS Biomater Sci. Eng."},{"key":"10.1016\/j.bioorg.2025.109057_bb0460","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.2147\/IJN.S402891","article-title":"Advances and prospects of prolamine corn protein zein as promising multifunctional drug delivery system for cancer treatment","author":"Luo","year":"2023","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bioorg.2025.109057_bb0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.inoche.2024.113300","article-title":"Co-biopolymer of zein\/starch hydrogel incorporated montmorillonite for efficient quercetin delivery in lung cancer treatment","volume":"170","author":"Pourmadadi","year":"2024","journal-title":"Inorg. Chem. Commun."},{"key":"10.1016\/j.bioorg.2025.109057_bb0470","article-title":"Zein nanoparticles for drug delivery: preparation methods and biological applications","volume":"635","author":"de Almeida Campos","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioorg.2025.109057_bb0475","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.3390\/ijms21082983","article-title":"Pharmacological inhibition of CA-IX impairs tumor cell proliferation, migration and invasiveness","volume":"21","author":"Ciccone","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.109057_bb0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2021.115800","article-title":"Up-regulation of PUMA caused the activation of p53 phosphorylation and acetylation, enhancing the interaction between PUMA and Bcl-X and mediating arsenic-induced apoptosis","volume":"434","author":"Zhou","year":"2022","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.109057_bb0485","doi-asserted-by":"crossref","first-page":"9795","DOI":"10.1080\/07391102.2023.2252082","article-title":"An outlook of docking analysis and structure-activity relationship of pyrimidine-based analogues as EGFR inhibitors against non-small cell lung cancer (NSCLC)","volume":"42","author":"Pal","year":"2024","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bioorg.2025.109057_bb0490","unstructured":"R. Pal, G.S.P. Matada, G. Teli, M.J. Akhtar, B. Kumar, Design, synthesis, and molecular profiling of pyrimidine-furan derivatives targeting EGFRWT, EGFRT790M, and EGFRL858R\/T790M\/C797S in NSCLC: In vitro and In silico evaluation, Chem. Biodivers., n\/a e202500549."},{"key":"10.1016\/j.bioorg.2025.109057_bb0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.141227","article-title":"Design, synthesis, and biological evaluation of novel 4-(4-ethoxyphenyl)-6-(substituted-phenyl)pyrimidin-2-amine\/thiol\/hydroxy derivatives as EGFRWT and EGFRT790M inhibitors targeting NSCLC: in-vitro and in-silico exploration","volume":"1327","author":"Pal","year":"2025","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2025.109057_bb0500","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1021\/acs.jcim.7b00293","article-title":"Fusion of structure and ligand based methods for identification of novel CDK2 inhibitors","volume":"57","author":"Mahajan","year":"2017","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2025.109057_bb0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104615","article-title":"Eco-friendly sequential one-pot synthesis, molecular docking, and anticancer evaluation of arylidene-hydrazinyl-thiazole derivatives as CDK2 inhibitors","volume":"108","author":"El-Naggar","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109057_bb0510","doi-asserted-by":"crossref","first-page":"106105","DOI":"10.1016\/j.fitote.2024.106105","article-title":"Novel coumarin-piperazine-2 (5H)-furanone hybrids as potential anti-lung cancer agents: synthesis, biological evaluation and molecular docking studies","volume":"177","author":"Zhang","year":"2024","journal-title":"Fitoterapia"},{"key":"10.1016\/j.bioorg.2025.109057_bb0515","doi-asserted-by":"crossref","first-page":"116527","DOI":"10.1016\/j.ejmech.2024.116527","article-title":"A new framework for novel analogues of pazopanib as potent and selective human carbonic anhydrase inhibitors: design, repurposing rational, synthesis, crystallographic, in vivo and in vitro biological assessments","author":"Hefny","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109057_bb0520","doi-asserted-by":"crossref","first-page":"106309","DOI":"10.1016\/j.bioorg.2022.106309","article-title":"Schiff bases as linker in the development of quinoline-sulfonamide hybrids as selective cancer-associated carbonic anhydrase isoforms IX\/XII inhibitors: a new regioisomerism tactic","volume":"131","author":"El-Malah","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109057_bb0525","first-page":"1","article-title":"A facile synthesis of Pyrido [: 3, 4] pyrazolo [1, 5-a] pyrimidine and Pyrido [: 3, 4] pyrazolo [5, 1-c][1, 2, 4] triazine bearing a Thiophene moiety","volume":"2013","author":"Elsaman","year":"2013","journal-title":"J. Chemother."},{"key":"10.1016\/j.bioorg.2025.109057_bb0530","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1039\/C8OB00627J","article-title":"An improved synthesis of pyrido [2, 3-d] pyrimidin-4 (1 H)-ones and their antimicrobial activity","volume":"16","author":"Fares","year":"2018","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bioorg.2025.109057_bb0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104527","article-title":"Pharmacophore hybridization approach to discover novel pyrazoline-based hydantoin analogs with anti-tumor efficacy","volume":"107","author":"Upadhyay","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109057_bb0540","doi-asserted-by":"crossref","unstructured":"O.L. Guterres Fernandes, T. Tizziani, B.P. Dambr\u00f3s, N. Ferreira de Sousa, C.L. Mansur Pontes, L.A.L. da Silva, L.A. Escorteganha Pollo, F.F. de Assis, M.T. Scotti, L. Scotti, A.L. Braga, M. Steindel, L.P. Sandjo, Studies of cytotoxicity effects, SARS-CoV-2 Main Protease Inhibition, and In Silico Interactions of Synthetic Chalcones, Chemistry & Biodiversity, vol. 20 (2023) e202201151.","DOI":"10.1002\/cbdv.202201151"},{"key":"10.1016\/j.bioorg.2025.109057_bb0545","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/ardp.201100005","article-title":"Synthesis and anti-bacterial activity of some heterocyclic Chalcone derivatives bearing Thiofuran, furan, and Quinoline moieties","volume":"344","author":"Zheng","year":"2011","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2025.109057_bb0550","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202400945","article-title":"Methoxy Chalcone derivatives: promising antimicrobial agents against Phytopathogens","volume":"21","author":"Santos","year":"2024","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.bioorg.2025.109057_bb0555","doi-asserted-by":"crossref","first-page":"8026","DOI":"10.1016\/j.bmc.2010.09.025","article-title":"Naphthylchalcones induce apoptosis and caspase activation in a leukemia cell line: the relationship between mitochondrial damage, oxidative stress, and cell death","volume":"18","author":"Winter","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109057_bb0560","doi-asserted-by":"crossref","first-page":"136804","DOI":"10.1016\/j.molstruc.2023.136804","article-title":"Novel chalcone derivatives of ursolic acid as acetylcholinesterase inhibitors: synthesis, characterization, biological activity, ADME prediction, molecular docking and molecular dynamics studies","volume":"1295","author":"\u015eenol","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2025.109057_bb0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127149","article-title":"Ultrasounds-mediated 10-seconds synthesis of chalcones as potential farnesyltransferase inhibitors","volume":"30","author":"Homerin","year":"2020","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.109057_bb0570","first-page":"1566","article-title":"2-Chloro-N-(4-sulfamoylphenyl) acetamide, Acta Crystallographica section E: structure reports","volume":"66","author":"Akkurt","year":"2010","journal-title":"Online"},{"key":"10.1016\/j.bioorg.2025.109057_bb0575","first-page":"073","article-title":"Synthesis, characterization and evaluation of new pyrazoline derivatives containing sulfonamide moiety as anti-microbial and anti-inflammatory agtents, journal of research in medical and dental","volume":"11","author":"Najmuldeen","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2025.109057_bb0580","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1039\/D3OB01599H","article-title":"Arylazo sulfones: multifaceted photochemical reagents and beyond","volume":"22","author":"Chawla","year":"2024","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bioorg.2025.109057_bb0585","first-page":"101150","article-title":"Synthesis, antimicrobial evaluation, and docking studies of new series Pyrazolone, pyrimidine, thiazine, and Pyranone derivatives bearing a sulfonamide moiety using ultrasound irradiation","author":"Ziwar","year":"2023","journal-title":"Res. Chem."},{"key":"10.1016\/j.bioorg.2025.109057_bb0590","doi-asserted-by":"crossref","first-page":"105657","DOI":"10.1016\/j.bioorg.2022.105657","article-title":"Lead optimization and biological evaluation of diazenylbenzenesulfonamides inhibitors against glyoxalase-I enzyme as potential anticancer agents","volume":"120","author":"Al-Oudat","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109057_bb0595","doi-asserted-by":"crossref","first-page":"111843","DOI":"10.1016\/j.ejmech.2019.111843","article-title":"Synthesis, biological and molecular dynamics investigations with a series of triazolopyrimidine\/triazole-based benzenesulfonamides as novel carbonic anhydrase inhibitors","volume":"185","author":"Said","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109057_bb0600","doi-asserted-by":"crossref","first-page":"7504","DOI":"10.1021\/acs.joc.3c00307","article-title":"Synthesis of 4-Aryl-1, 3, 4-benzotriazepinones from Isatoic anhydrides and Hydrazonyl chlorides","volume":"11","author":"Zhang","year":"2023","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.bioorg.2025.109057_bb0605","doi-asserted-by":"crossref","first-page":"8873","DOI":"10.1021\/acs.jmedchem.5c00526","article-title":"Shooting an arrow against convulsion: novel Triazole-grafted Benzenesulfonamide derivatives as carbonic anhydrase II and VII inhibitors","volume":"68","author":"Zeidan","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109057_bb0610","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116527","article-title":"A new framework for novel analogues of pazopanib as potent and selective human carbonic anhydrase inhibitors: design, repurposing rational, synthesis, crystallographic, in vivo and in vitro biological assessments","volume":"274","author":"Hefny","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109057_bb0615","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1080\/14756366.2022.2056734","article-title":"Novel 3-(6-methylpyridin-2-yl)coumarin-based chalcones as selective inhibitors of cancer-related carbonic anhydrases IX and XII endowed with anti-proliferative activity","volume":"37","author":"Tawfik","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109057_bb0620","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bioorg.2025.109057_bb0625","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106799","article-title":"Novel 4-(2-arylidenehydrazineyl)thienopyrimidine derivatives as anticancer EGFR inhibitors: design, synthesis, biological evaluation, kinome selectivity and in silico insights","volume":"140","author":"Elsebaie","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109057_bb0630","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2023.2241674","article-title":"Recruitment of hexahydroquinoline as anticancer scaffold targeting inhibition of wild and mutants EGFR (EGFRWT, EGFRT790M, and EGFRL858R)","volume":"38","author":"Abo Al-Hamd","year":"2023","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109057_bb0635","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3390\/ph15040481","article-title":"New genetic bomb trigger: design, synthesis, molecular dynamics simulation, and biological evaluation of novel BIBR1532-related analogs targeting telomerase against non-small cell lung Cancer","volume":"15","author":"Tawfik","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2025.109057_bb0640","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1080\/14756366.2022.2120478","article-title":"Discovery of new symmetrical and asymmetrical nitrile-containing 1,4-dihydropyridine derivatives as dual kinases and P-glycoprotein inhibitors: synthesis, in vitro assays, and in silico studies","volume":"37","author":"Saad","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109057_bb0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105708","article-title":"Exploration of novel VEGFR2 tyrosine kinase inhibitors via design and synthesis of new alkylated indolyl-triazole Schiff bases for targeting breast cancer","volume":"122","author":"Nafie","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109057_bb0650","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107101","article-title":"Development of new thieno[2,3-d]pyrimidines as dual EGFR and STAT3 inhibitors endowed with anticancer and pro-apoptotic activities","volume":"143","author":"Elsebaie","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109057_bb0655","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109087","article-title":"Triaryl dicationic DNA minor-groove binders with antioxidant activity display cytotoxicity and induce apoptosis in breast cancer","volume":"324","author":"Nafie","year":"2020","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bioorg.2025.109057_bb0660","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115828","article-title":"Discovery of novel pyrazolo [3, 4-b] pyridine scaffold-based derivatives as potential PIM-1 kinase inhibitors in breast cancer MCF-7 cells","volume":"28","author":"Nafie","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109057_bb0665","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.3390\/molecules25112523","article-title":"Discovery of new apoptosis-inducing agents for breast cancer based on ethyl 2-amino-4, 5, 6, 7-tetra hydrobenzo [b] thiophene-3-carboxylate: synthesis, in vitro, and in vivo activity evaluation","volume":"25","author":"Gad","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.109057_bb0670","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/cbdd.13791","article-title":"Antimicrobial and antiproliferative activities of novel synthesized 6-(quinolin-2-ylthio) pyridine derivatives with molecular docking study as multi-targeted JAK2\/STAT3 inhibitors","volume":"97","author":"Nafie","year":"2021","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bioorg.2025.109057_bb0675","doi-asserted-by":"crossref","first-page":"1120251","DOI":"10.3389\/fphar.2023.1120251","article-title":"Zein-based nanoparticles: preparation, characterization, and pharmaceutical application","volume":"14","author":"Liu","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.109057_bb0680","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.3390\/polym15061464","article-title":"Oral delivery of psoralidin by mucoadhesive surface-modified bilosomes showed boosted apoptotic and necrotic effects against breast and lung cancer cells","volume":"15","author":"Youness","year":"2023","journal-title":"Polymers"},{"key":"10.1016\/j.bioorg.2025.109057_bb0685","doi-asserted-by":"crossref","first-page":"7228","DOI":"10.1021\/acsapm.2c01093","article-title":"Peganum harmala alkaloids and tannic acid encapsulated in PAMAM dendrimers: improved anticancer activities as compared to doxorubicin","volume":"4","author":"Azzazy","year":"2022","journal-title":"ACS Appl. Polymer Materials"},{"key":"10.1016\/j.bioorg.2025.109057_bb0690","doi-asserted-by":"crossref","first-page":"8392","DOI":"10.3390\/ijms24098392","article-title":"Co-delivery of Ylang Ylang oil of Cananga odorata and Oxaliplatin using intelligent pH-sensitive lipid-based Nanovesicles for the effective treatment of triple-negative breast Cancer","volume":"24","author":"Sedky","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.109057_bb0695","doi-asserted-by":"crossref","first-page":"5399","DOI":"10.1039\/D3NA00368J","article-title":"Box\u2013Behnken design of thermo-responsive nano-liposomes loaded with a platinum (IV) anticancer complex: evaluation of cytotoxicity and apoptotic pathways in triple negative breast cancer cells","volume":"5","author":"Sedky","year":"2023","journal-title":"Nanoscale Adv."},{"key":"10.1016\/j.bioorg.2025.109057_bb0700","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2023.104820","article-title":"Green extraction of essential oils from Pistacia lentiscus resins: encapsulation into Niosomes showed improved preferential cytotoxic and apoptotic effects against breast and ovarian cancer cells","volume":"87","author":"Fahmy","year":"2023","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.bioorg.2025.109057_bb0705","doi-asserted-by":"crossref","first-page":"9004","DOI":"10.1021\/acs.jmedchem.5b01343","article-title":"Efficient expression and crystallization system of cancer-associated carbonic anhydrase isoform IX","volume":"58","author":"Leitans","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109057_bb0710","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3389\/fcimb.2020.00107","article-title":"Prevalence and therapies of antibiotic-resistance in Staphylococcus aureus","volume":"10","author":"Guo","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.bioorg.2025.109057_bb0715","doi-asserted-by":"crossref","first-page":"9967","DOI":"10.1080\/07391102.2022.2158134","article-title":"Exploring the possibility of drug repurposing for cancer therapy targeting human lactate dehydrogenase a: a computational approach","volume":"41","author":"Paul","year":"2023","journal-title":"J. Biomol. Struct. Dyn."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682500937X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682500937X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T19:09:39Z","timestamp":1763665779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004520682500937X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":143,"alternative-id":["S004520682500937X"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109057","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Innovative design and synthesis of dual-acting hCA IX\/CDK-2 inhibitors through hetero ring fused pyrimidine utilization for cutting-edge anticancer therapy: Zein nanoparticles for in vivo lung cancer treatment","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109057"}}